Case 34-2005: A 10-year-old girl with a bullous skin eruption and acute respiratory failure

New England Journal of Medicine

Volumn 353, Issue 19, 2005, Pages 2057-2066

  Sheridan, Robert L ^a,b,d   Liu, Vincent ^c,d   Anupindi, Sudha ^c,d  

^a Shriners Hospital for Children   (United States)

^b Division of Burns   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CEFTRIAXONE; DIAZEPAM; LORAZEPAM;

ACUTE RESPIRATORY FAILURE; ARTICLE; BULLOUS SKIN DISEASE; CASE REPORT; ELECTROENCEPHALOGRAM; FEMALE; GASTROENTERITIS; HOSPITAL ADMISSION; HUMAN; HYPERSENSITIVITY REACTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RASH; RESPIRATORY FAILURE; SCHOOL CHILD; SEIZURE; TIME SERIES ANALYSIS; ADULT RESPIRATORY DISTRESS SYNDROME; CHILD; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; LUNG; PATHOLOGY; RADIOGRAPHY; SKIN; TOXIC EPIDERMAL NECROLYSIS;

CARBAMAZEPINE; CHILD; DIAGNOSIS, DIFFERENTIAL; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; LUNG; RESPIRATORY DISTRESS SYNDROME, ADULT; SEIZURES; SKIN; SKIN DISEASES, VESICULOBULLOUS;

EID: 27744600245     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc059029     Document Type: Article

References (32)

1. Yeh SW, Ahmed B, Sami N, Razzaque Ahmed A. Blistering disorders: diagnosis and treatment. Dermatol Ther 2003;16:214-23.
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85.
3. Rasmussen JE. Erythema multiforme: should anyone care about the standards of care? Arch Dermatol 1995;131:726-9.
4. Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003;4:561-72.
5. Lyell A. Toxic epidermal necrolysis. Lancet 1969;1:1155.
6. Lyell A. Idem. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol 1979;100:69-86.
7. Roujeau JC, Revuz J. Toxic epidermal necrolysis: an expanding field of knowledge. J Am Acad Dermatol 1994;31:301-2.
8. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-6.
9. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
10. Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-3.
11. Palmieri TL, Greenhalgh DG, Saffle JR, et al. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 2002;23:87-96.
12. Sheridan RL, Briggs SE, Remensnyder JP, et al. The burn unit as a resource for the management of acute nonburn conditions in children. J Burn Care Rehabil 1995;16:62-4.
13. Marvin JA, Heimbach DM, Engrav LH, Harnar TJ. Improved treatment of the Stevens-Johnson syndrome. Arch Surg 1984;119:601-5.
14. Wong KC, Kennedy PJ, Lee S. Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis. Australas J Dermatol 1999;40:131-4.
15. Sheridan RL, Weber JM, Schulz JT, Ryan CM, Low HM, Tompkins RG. Management of severe toxic epidermal necrolysis in children. J Burn Care Rehabil 1999;20:497-500.
16. Schulz JT, Sheridan RL, Ryan CM, MacKool B, Tompkins RG. A 10-year experience with toxic epidermal necrolysis. J Burn Care Rehabil 2000;21:199-204.
17. Heimbach DM, Engrav LH, Marvin JA, Harnar TJ, Grube BJ. Toxic epidermal necrolysis: a step forward in treatment. JAMA 1987;257:2171-5. [Erratum, JAMA 1987;258:1894.]
18. Birchall N, Langdon R, Cuono C, McGuire J. Toxic epidermal necrolysis: an approach to management using cryopreserved allograft skin. J Am Acad Dermatol 1987;16:368-72.
19. Weber JM, Sheridan RL, Schulz JT, Tompkins RG, Ryan CM. Effectiveness of bacteria-controlled nursing units in preventing cross-colonization with resistant bacteria in severely burned children. Infect Control Hosp Epidemiol 2002;23:549-51.
20. Power WJ, Ghoraishi M, Merayo-Lloves J, Neves RA, Foster CS. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology 1995;102:1669-76.
21. Wilkins J, Morrison L, White CR Jr. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Dermatol Clin 1992;10:571-82.
22. Sheridan RL, Hinson M, Nackel A, et al. Development of a pediatric burn pain and anxiety management program. J Burn Care Rehabil 1997;18:455-9.
23. McIvor RA, Zaidi J, Peters WJ, Hyland RH. Acute and chronic respiratory complications of toxic epidermal necrolysis. J Burn Care Rehabil 1996;17:237-40.
24. Lebargy F, Wolkenstein P, Gisselbrecht M, et al. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med 1997;23:1237-44.
25. Sheridan RL, Zapol WM, Ritz RH, Tompkins RG. Low-dose inhaled nitric oxide in acutely burned children with profound respiratory failure. Surgery 1999;126:856-62.
26. Sheridan RL, Kacmarek RM, McEttrick MM, et al. Permissive hypercapnia as a ventilatory strategy in burned children: effect on barotrauma, pneumonia, and mortality. J Trauma 1995;39:854-9.
27. Sheridan R, Remensnyder J, Prelack K, Petras L, Lydon M. Treatment of the seriously burned infant. J Burn Care Rehabil 1998;19:115-8.
28. Prelack K, Cunningham JJ, Sheridan RL, Tompkins RG. Energy and protein provisions for thermally injured children revisited: an outcome-based approach for determining requirements. J Burn Care Rehabil 1997;18:177-81.
29. Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 2003;139:33-6.
30. Brown KM, Silver GM, Halerz M, Walaszek P, Sandroni A, Gamelli RL. Toxic epidermal necrolysis: does immunoglobulin make a difference? J Burn Care Rehabil 2004;25:81-8.
31. Bastuji-Garin S, Zahedi M, Guillaume JC, Roujeau JC. Toxic epidermal necrolysis (Lyell syndrome) in 77 elderly patients. Age Ageing 1993;22:450-6.
32. Sheridan RL, Schulz JT, Ryan CM, et al. Long-term consequences of toxic epidermal necrolysis in children. Pediatrics 2002;109:74-8.